Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol
Open Access
- 1 January 2005
- Vol. 54 (1) , 171-172
- https://doi.org/10.1136/gut.2004.049031
Abstract
We report a patient with vWD who had suffered recurrent and life threatening bleeding from the gastrointestinal tract in whom, despite an extensive investigation, no apparent cause of haemorrhage was identified. He was successfully treated with combined administration of octreotide LAR (long active released) and propranolol. This is the first report on the use of octreotide LAR in a patient with vWD.Keywords
This publication has 8 references indexed in Scilit:
- Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tractDigestive and Liver Disease, 2001
- How I treat patients with von Willebrand diseaseBlood, 2001
- Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's diseaseBritish Journal of Haematology, 2000
- The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tractAlimentary Pharmacology & Therapeutics, 1999
- Long-acting formulations of somatostatin analogues.1999
- Octreotide Long-Acting Release (LAR)Drugs, 1997
- Somatostatin in the Treatment of Gastrointestinal Bleeding Caused by AngiodysplasiaScandinavian Journal of Gastroenterology, 1996
- Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine.1993